Suppr超能文献

完全性房室传导阻滞并不会降低接受心脏再同步治疗的永久性房颤患者的长期死亡率。

Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy.

机构信息

Thorax Institute, Cardiology Department, Hospital Clinic, Universitat de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Catalonia, Spain.

出版信息

Eur J Heart Fail. 2013 Dec;15(12):1412-8. doi: 10.1093/eurjhf/hft114. Epub 2013 Jul 11.

Abstract

AIMS

A maximum percentage of ventricular pacing is mandatory to obtain a good response to CRT. Atrioventricular junction (AVJ) ablation has been recommended to attain this objective in patients with AF.

THE AIMS OF OUR STUDY WERE

(i) to determine whether the presence of complete AVJ block (induced or spontaneous) improves survival in patients with permanent AF treated with CRT and (ii) to analyse the predictors of mortality in AF patients treated with CRT.

METHODS AND RESULTS

From a series of 608 patients treated with CRT in our centre from 2000 to 2011, a cohort of 155 patients with permanent AF was analysed. Patients in AF were divided into two groups, AF + AVJ block [76 (49%)] and AF non-AVJ block [79 (51%)]. Mean follow-up was 30 months (interquartile range 13-51 months). During the follow-up, 62 patients died. Overall and cardiovascular mortality were similar between both groups: hazard ratio (HR) 0.85, 95% confidence interval (CI) 0.51-1.39, P = 0.51 and HR 0.94, 95% CI 0.52-1.68, P = 0.82. Multivariate analysis identified three independent predictors of mortality: basal NYHA functional class IV (HR 2.25, 95% CI 1.12-4.22, P = 0.03), glomerular filtration rate (HR 0.98, 95% CI 0.96-0.99, P = 0.03), and LVEF (HR 0.94, 95% CI 0.89-0.99, P = 0.02).

CONCLUSIONS

AVJ block did not improve survival for patients in AF treated with CRT. Basal NYHA functional class IV, poor renal function, and LVEF were the independent predictors of mortality.

摘要

目的

为了获得 CRT 的良好反应,需要最大限度地减少心室起搏。在房颤患者中,已经推荐房室结(AVJ)消融来达到这一目标。

我们研究的目的是

(i)确定永久性房颤患者接受 CRT 治疗时完全 AVJ 阻滞(诱导或自发)的存在是否改善生存;(ii)分析接受 CRT 治疗的房颤患者死亡的预测因素。

方法和结果

在 2000 年至 2011 年期间,我们中心对 608 例接受 CRT 治疗的患者进行了一系列研究,其中分析了 155 例永久性房颤患者的队列。房颤患者分为两组,房颤+AVJ 阻滞[76 例(49%)]和房颤非-AVJ 阻滞[79 例(51%)]。平均随访时间为 30 个月(四分位距 13-51 个月)。随访期间,62 例患者死亡。两组患者的总死亡率和心血管死亡率相似:危险比(HR)0.85,95%置信区间(CI)0.51-1.39,P=0.51 和 HR 0.94,95% CI 0.52-1.68,P=0.82。多变量分析确定了死亡率的三个独立预测因素:基础纽约心脏病协会(NYHA)功能分级 IV(HR 2.25,95%CI 1.12-4.22,P=0.03)、肾小球滤过率(HR 0.98,95%CI 0.96-0.99,P=0.03)和左心室射血分数(LVEF)(HR 0.94,95%CI 0.89-0.99,P=0.02)。

结论

AVJ 阻滞并未改善接受 CRT 治疗的房颤患者的生存。基础 NYHA 功能分级 IV、肾功能差和 LVEF 是死亡率的独立预测因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验